Sulphonamides and Trimethoprim. Fluoroquinolones Flashcards
General Background Info On Sulphonamides and Trimethoprim
Are folate antagonists–> inhibit folic acid metabolism
Are Antimetabolites–> inhibits cell growth by competing with/substituting for a natural substrate
Folate
Cofactor as methyl group donor in synth of purines and
pyrimidines–> req. for DNA and RNA synth
Humans can’t synthesise, need to absorb
Bacteria can synthesise, can’t absorb
Active in THF form; both humans and bacteria need to
activate it
Synthesis and Activation of Folate
3 Steps
p Aminobenzoic Acid via Dihydropteroayte synthase–>
Dihydrofolic Acid via Dihydrofolate reductase–>
Tetrahydrofolic Acid
Point of Action: Sulphonamides and Trimethoprim in Folic Acid Synthesis
Sulphonamides: Dihydropteroate Synthase
do so as they have similar structure to PABA
Trimethoprim: Dihydrofolate Reductase
Toxicity of Sulphonamides and Trimethoprim
Class II of selective toxicity meaning
block synth of simple block of cell (NA/AA/sugar)
Inhibition of folate metabolism is bacteriostatic effect
General Information of Sulphonamides
Synthetic structural analoges of PABA
Compete with PABA for dihydropteroate synthase
as the enzyme is dominant in bacteria–> selective toxicity
Counteract the effect of sulphonamides by adding PABA
Sulphonamides
Pharmacokinetics
Spectrum
MoR
Good oral bioavail.–> per os
Distributes if total water space
Crosses BBB and placenta
Strong PPB–> displacement
Elimination
Biotransformation (acetylation)
Excreted into urine and milk
Spectrum
G+: Streptococci, Staph
G-: E. Coli, Shigella, Salmonella
Chlamydia, Nocardia
MoR
Anaerobic bacteria show natural resistance
Overproduction or mutation of enzyme–> resistance
Sulphonamides
Uses
SE
Not given topically –> risk of allergic reactions
Nocardiosis
Travellers Diarrhoea
Toxoplasmosis
UTI and upper resp. infections
SE
Allergies: skin
Metabolites may precipitate in kidney failure
–>crystalluria
Anaemia, haemolysis
ICTERUS (bilirubin displaced from albumin)
Can be avoided by stimulating elimination: alkalising
urine–> ionisation–> elimination
Admin of diuretics
STIMULATE GROWTH OF RICKETTSIA
Sulphonamides
Interactions
Local Anaesthetics ex. procain can antagonise effect
as procaine is a PABA ester
Kernicterus due to displacement of bilirubin from PP
Comb with dihydrofolate reductase inhibitors
Decreases resistance
Synergism
Sulphonamides
Drug Groups
Short Acting
Intermediate Acting
Long Acting
Sulphonamides
Short Acting
Sulfadiazine and Sulfadimidine
Sulphonamides
Intermediate Acting
Sulfamethoxazole
Sulphonamides
Long Acting
Sulfadimethoxine Sulfadoxine
Long acting due to strong PPB or renal reabsorption
Sulfadoxine can also be used in malaria prophylaxis
OTHER: sulfasalazine
also used in RA, UC
Trimethoprim
General
MoA
Chemically related to pyrimthamine (sulfonamide)
MoA
structural folate analogue: competitively inhibits
dihydrofolate reductase –> bacteriostatic
Also affects DNA and RNA synthesis of humans but has
a much stronger affinity to bacterial dihydrofolate
reductase
Trimethoprim
Pharmacokinetics
Resistance
Use
SE
Good oral bioavailability–> per os
Distributed throughout; passes BBB
Excreted renally
Resistance by mutation and overprod. of enzyme
Uses: UTI and Resp Infection
SE
folate deficiency–> megaloblastic anaemia
nausea vomiting
SHOULD BE GIVEN WITH FOLIC ACID (same with sulphonamides)
Combination: Sulphonamides and dihydrofolate reductase inhibitor
Trimethoprim and Sulfamethaxazole= CO TRIMOXAZOLE
Potentiate each other
Wider spectrum; decreased resistance
Drugs have similar half life